Bamlanivimab is the first coronavirus antibody treatment to be approved in Canada.

The therapy is still undergoing additional testing to establish its safety and effectiveness.

The paused trial, which Lilly calls ACTIV-3, focused on hospitalized patients.

The company said the move was out of "an abundance of caution."

Trump falsely claimed that a therapeutic drug is the same as a cure during an interview with Fox Business.

Eli Lilly & Co. reported Wednesday that an experimental medication might slow mild Alzheimer's if people take it early enough, one of a handful of drugs in late-stage testing in the frustrating hunt for a better treatment.